$506 Million

10x Genomics, Inc.

Follow-on Offering

Bookrunner, September 2020

10x Genomics, Inc. is a life science technology company building products to interrogate, understand and master biology. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company has built deep expertise across diverse disciplines including chemistry, biology, hardware and software. Innovations in all of these areas have enabled their rapidly expanding suite of products, which allows the Company’s customers to interrogate biological systems at previously inaccessible resolution and scale. The Company’s products have enabled researchers to make fundamental discoveries across multiple areas of biology, including oncology, immunology and neuroscience, and have helped empower the single cell revolution.

More Like This

Sep 2020
$86 Million

Follow-on Offering

Bookrunner

View Details
Sep 2020
$80 Million

Follow-on Offering

Lead Left Bookrunner

View Details
Sep 2020
$150 Million

Follow-on Offering

Lead Left Bookrunner

View Details